Who
Ronen Rosenbloom
Director
Company insider
Files Form 4 as: Director, Nexentis Technologies.
In numbers
- Trades disclosed
- 3
- Buys
- 2
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 20 Dec 2023
- Last trade
- 15 Oct 2026
- Last filed
- 19 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 19 Oct 2026 | NXTS Nexentis TechnologiesBiotechnology | SEC FORM 4 Code A | —19,375 at $0.00 | filing |
| 23 Dec 2024filed 26 Dec 2024 | NXTS Nexentis TechnologiesBiotechnology | SEC FORM 4 Bought | —50,000 at $0.00 | filing |
| 20 Dec 2023filed 26 Dec 2023 | NXTS Nexentis TechnologiesBiotechnology | SEC FORM 4 Bought | —14,500 at $0.00 | filing |
News
Critical Analysis: Nexentis Technologies (NASDAQ:NXTS) versus Pfizer (NYSE:PFE)NXTS · dailypolitical.com · 19 Oct 2026
0 headlines in the last 90 days name Ronen Rosenbloom; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.